40 studies found for:    Open Studies | Exclude Unknown | liver | NIDDK
Show Display Options
Rank Status Study
21 Recruiting Seroprevalence of Hepatitis E in People With an Organ Transplant
Condition: Hepatitis E
Intervention:
22 Recruiting UAB HRFD Core Center: Core A: The Hepato/Renal Fibrocystic Diseases Translational Resource
Conditions: Hepato/Renal Fibrocystic Disease;   Autosomal Recessive Polycystic Kidney Disease;   Joubert Syndrome;   Bardet Biedl Syndrome;   Meckel-Gruber Syndrome;   Congenital Hepatic Fibrosis;   Caroli Syndrome;   Oro-Facial-Digital Syndrome Type I;   Nephronophthisis;   Glomerulocystic Kidney Disease
Intervention:
23 Recruiting Entecavir/Pegylated Interferon in Immune Tolerant Children With Chronic Hepatitis B Virus (HBV) Infection
Condition: Hepatitis B
Intervention: Drug: Entecavir and peginterferon
24 Recruiting Combination Therapy of Pegylated Interferon Alfa-2a and Tenofovir Versus Tenofovir Monotherapy in Chronic Hepatitis B
Condition: Hepatitis B
Interventions: Drug: Tenofovir;   Drug: Peginterferon-alfa 2a and tenofovir
25 Recruiting Combination Entecavir and Peginterferon Therapy in HBeAg-Positive Immune-Tolerant Adults With Chronic Hepatitis B
Condition: Hepatitis B
Intervention: Drug: Entecavir and peginterferon
26 Recruiting Observational Study of Persons With Hepatitis B Virus Infection in North America
Conditions: Chronic Hepatitis B e Antigen Positive;   Chronic Hepatitis B e Antigen Negative
Intervention:
27 Recruiting Tenofovir DF With or Without Peginterferon for Chronic Hepatitis B
Conditions: Chronic Hepatitis B e Antigen Negative;   Chronic Hepatitis B e Antigen Positive
Intervention: Drug: Peginterferon and Tenofovir
28 Recruiting Withdrawal of Therapy After Long-Term Antiviral Treatment for Chronic Hepatitis B
Conditions: Chronic Hepatitis B e Antigen Positive;   Chronic Hepatitis B e Antigen Negative
Intervention:
29 Recruiting Evaluation of Safety, Tolerability, and Antiviral Activity of Chlorcyclizine HCl Alone or in Combination With Ribavirin in Patients With Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: Chlorcyclizine HCL with Ribavirin;   Drug: Chlorcyclizine HCL
30 Recruiting Immune Response to Hepatitis C Virus
Condition: Hepatitis C
Intervention:
31 Recruiting Lonafarnib for Chronic Hepatitis D
Condition: Hepatitis D
Intervention: Drug: Lonafarnib
32 Recruiting Tenofovir Alone Versus Tenofovir With Emtricitabine to Treat Chronic Hepatitis B
Condition: Hepatitis B
Interventions: Drug: Tenofovir/ & amp;  Emtricitabine;   Drug: Tenofovir
33 Recruiting Clinical Diagnosis of Acute Porphyria
Conditions: Hereditary Coproporphyria (HCP);   Acute Intermittent Porphyria (AIP);   Variegate Porphyria (VP)
Intervention:
34 Recruiting HBRN: Immune Regulation and Costimulation in Natural History of Chronic Hepatitis B
Condition: Hepatitis B
Intervention:
35 Recruiting HBRN: Immune Regulation and Costimulation in Natural History and Therapeutic Outcome of Chronic Hepatitis B
Condition: Hepatitis B
Intervention:
36 Recruiting Hepatitis B Research Network Adult Cohort Study
Condition: Hepatitis B
Intervention:
37 Recruiting Erythropoietic Protoporphyrias: Studies of the Natural History, Genotype-Phenotype Correlations, and Psychosocial Impact
Conditions: Erythropoietic Protoporphyria;   EPP;   X-Linked Protoporphyria;   XLP;   XLPP;   X-Linked Dominant Erythropoietic Protoporphyria;   XLEPP;   XLDP
Intervention:
38 Recruiting Hepatitis B Research Network Pediatric Cohort Study (HBRN)
Condition: Hepatitis B
Intervention:
39 Recruiting Peers for Promoting Adolescent Transplant Health
Condition: Behavior and Behavior Mechanisms
Interventions: Behavioral: Peer Mentoring;   Behavioral: e-Communication with mentor
40 Recruiting Study of Losartan in the Treatment of NAFLD in Children
Condition: NAFLD
Intervention: Drug: Losartan

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page   
Indicates status has not been verified in more than two years